Businessweek

On March 27, 2013, a lawsuit was filed against D. Medical Industries Ltd., Mr. Yaacov Bar Lev and Mr. Shimon Cohen at the Israeli labor court in Tel Aviv. The lawsuit was filed by Mr. David Schwartz, formerly the chief executive officer and the chairman of the board of directors of the company. Pursuant to the lawsuit, Mr. Schwartz claims that the company owes him a total amount of ILS 644,125 due to services granted by Mr. Schwartz to the company as the chief executive officer and chairman of the board of directors of the company. The company has thirty days to respond to the lawsuit. As of the date of this report, the company reviews the lawsuit to evaluate the claims included therein. On March 12, 2013, Mr. Youval Mor-Mously was appointed as member of the company's board of directors, effective immediately. Mr. Mor-Mously was also appointed as a member of the board of directors' compensation and the board directors' committee for the examination of financial statements.

D. Medical Industries Ltd. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Ordinary Shares, nominal par value ILS per share under the Securities Exchange Act of 1934, as amended.

D. Medical Industries Ltd., Special/Extraordinary Shareholders Meeting, Mar 20, 2013., at 11:00 Israel Standard Time.

D. Medical Industries Ltd., Special/Extraordinary Shareholders Meeting, Apr 03, 2013., at 11:00 Israel Standard Time. Agenda: To consider election of Mr. Liav Even-Chen as external director of the company for a three-year term.

D. Medical Industries Ltd. announced that Ms. Orly Solomon was appointed as the company's chief executive officer effective as of February 19, 2013. The company has terminated the tenure of Mr. David Schwartz, the company's former chief executive officer, effective as of February 11, 2013. Mr. Schwartz also resigned from his position as a member of the company's board of directors effective as of February 19, 2013. Mr. Uri Ben-Ari was appointed as the company's chief financial officer effective as of February 6, 2013. Mr. David Dana, the company's former chief financial officer, has terminated his employment as of February 6, 2013 (rather than March 3, 2013 as originally reported on January 3, 2013. Dr. Mati Nof and Prof. Baruch Mevorach have resigned from their positions as directors of the company effective as of January 13, 2013. In addition, Prof. Yitzhak Katz has resigned from his position as an external director of the company effective as of January 14, 2013.